Article info
Clinical and epidemiological research
Concise report
Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis
- Correspondence to Laura K Hummers, Johns Hopkins Scleroderma Center, 5501 Hopkins Bayview Circle, Room 1B.7, Baltimore, MD 21224, USA; lhummers{at}jhmi.edu
Citation
Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis
Publication history
- Accepted January 23, 2011
- First published March 6, 2011.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions